LPL Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$151K Buy
16,852
+2,050
+14% +$18.4K ﹤0.01% 5025
2025
Q1
$111K Buy
14,802
+870
+6% +$6.53K ﹤0.01% 4889
2024
Q4
$105K Sell
13,932
-1,940
-12% -$14.6K ﹤0.01% 4864
2024
Q3
$121K Sell
15,872
-1,760
-10% -$13.4K ﹤0.01% 4753
2024
Q2
$109K Buy
17,632
+1,215
+7% +$7.51K ﹤0.01% 4625
2024
Q1
$83.4K Sell
16,417
-1,020
-6% -$5.18K ﹤0.01% 4630
2023
Q4
$104K Sell
17,437
-1,240
-7% -$7.43K ﹤0.01% 4477
2023
Q3
$132K Sell
18,677
-10,033
-35% -$71K ﹤0.01% 4304
2023
Q2
$202K Buy
28,710
+1,336
+5% +$9.41K ﹤0.01% 4097
2023
Q1
$228K Buy
27,374
+3,069
+13% +$25.6K ﹤0.01% 3919
2022
Q4
$279K Buy
24,305
+2,228
+10% +$25.6K ﹤0.01% 3678
2022
Q3
$278K Buy
22,077
+818
+4% +$10.3K ﹤0.01% 3633
2022
Q2
$225K Sell
21,259
-6,075
-22% -$64.3K ﹤0.01% 3824
2022
Q1
$444K Buy
27,334
+2,464
+10% +$40K ﹤0.01% 3283
2021
Q4
$344K Sell
24,870
-38,595
-61% -$534K ﹤0.01% 3576
2021
Q3
$912K Sell
63,465
-14,653
-19% -$211K ﹤0.01% 2671
2021
Q2
$1.24M Buy
78,118
+35,811
+85% +$566K ﹤0.01% 2386
2021
Q1
$430K Buy
42,307
+22,938
+118% +$233K ﹤0.01% 3143
2020
Q4
$144K Sell
19,369
-70
-0.4% -$520 ﹤0.01% 3594
2020
Q3
$67K Buy
+19,439
New +$67K ﹤0.01% 3390
2019
Q3
Sell
-32,733
Closed -$124K 3286
2019
Q2
$124K Sell
32,733
-2,000
-6% -$7.58K ﹤0.01% 3117
2019
Q1
$283K Buy
34,733
+1,600
+5% +$13K ﹤0.01% 2677
2018
Q4
$267K Sell
33,133
-1,750
-5% -$14.1K ﹤0.01% 2547
2018
Q3
$266K Sell
34,883
-1,000
-3% -$7.63K ﹤0.01% 2776
2018
Q2
$206K Buy
35,883
+2,900
+9% +$16.6K ﹤0.01% 2939
2018
Q1
$157K Sell
32,983
-1,675
-5% -$7.97K ﹤0.01% 2994
2017
Q4
$170K Buy
+34,658
New +$170K ﹤0.01% 2828